secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alzamend Neuro, Inc. (ALZN)
CIK:        0001677077
Form:       8-K
Filed at:   2023-10-30T23:59:59+00:00
Accession:  0001214659-23-014086
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alzamend Neuro announces 1-for-15 reverse stock split to regain Nasdaq compliance
--------------------------------------------------------------------------------

- Reverse stock split at 1-for-15 ratio effective 12:01 AM ET on October 31, 2023.
- Outstanding shares reduce from ~97M to ~6.47M; par value unchanged at $0.0001.
- Split intended to regain compliance with Nasdaq $1.00 minimum bid price requirement.
- No fractional shares; cash paid in lieu; new CUSIP 02262M407.
- Board approved Oct 17, 2023; stockholders authorized at special meeting Sep 29, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1677077/000121465923014086/0001214659-23-014086-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1677077/000121465923014086/o10272358k.htm
  HTML page:      https://secwatch.observer/filing/0001214659-23-014086

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer